Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Argiris Symeonidis

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
STAR Protocols|June 22, 2026
Protocol for mitochondrial DNA extraction, purity evaluation, and global methylation assessment via LC-MS/MSArgyri Chroni, Theodora Alexiou, John Zafeiropoulos, et al.
Frontiers in Oncology|August 22, 2022
Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative DisordersArgiris Symeonidis, Spiros Chondropoulos, Evgenia Verigou, et al.
Cancers|November 26, 2022
Bone Marrow Immune Microenvironment in Myelodysplastic SyndromesOlga Kouroukli, Argiris Symeonidis, Periklis Foukas, et al.
Plos One|February 27, 2024
Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancerKalliopi Zafeiropoulou, Georgios Kalampounias, Spyridon Alexis, et al.
Frontiers in Oncology|May 2, 2022
Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and ManagementThomas P Thomopoulos, Argiris Symeonidis, Alexandra Kourakli, et al.
Cureus|January 3, 2024
Lower-Risk Myelodysplastic Syndrome (MDS) Patients Exhibit Diminished Proteasome Proteolytic Activity and High Intracellular Reactive Oxygen Species (ROS) LevelsKalliopi Zafeiropoulou, Georgios Kalampounias, Spyridon Alexis, et al.
Frontiers in Oncology|November 15, 2024
Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification eraEvgenia Verigou, Theodora Chatzilygeroudi, Vasileios Lazaris, et al.
Annals of Hematology|October 26, 2019
Reversal of skin changes in smoldering myeloma with clinical presentation of POEMS syndrome with a lenalidomide-based regimenElena E Solomou, Panayiotis Marnellos, Agathoclis Agathokleous, et al.
Leukemia Research|June 19, 2004
Impaired clonogenic growth of myelodysplastic bone marrow progenitors in vitro is irrelevant to their apoptotic stateSotiria Michalopoulou, Ilina Micheva, Alexandra Kouraklis-Symeonidis, et al.
Current Issues in Molecular Biology|January 24, 2025
Prognostic Value of PSMB5 and Correlations with LC3II and Reactive Oxygen Species Levels in the Bone Marrow Mononuclear Cells of Bortezomib-Resistant Multiple Myeloma PatientsEva Plakoula, Georgios Kalampounias, Spyridon Alexis, et al.
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
STAR Protocols|June 22, 2026
Protocol for mitochondrial DNA extraction, purity evaluation, and global methylation assessment via LC-MS/MSArgyri Chroni, Theodora Alexiou, John Zafeiropoulos, et al.
Frontiers in Oncology|August 22, 2022
Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative DisordersArgiris Symeonidis, Spiros Chondropoulos, Evgenia Verigou, et al.
Cancers|November 26, 2022
Bone Marrow Immune Microenvironment in Myelodysplastic SyndromesOlga Kouroukli, Argiris Symeonidis, Periklis Foukas, et al.
Plos One|February 27, 2024
Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancerKalliopi Zafeiropoulou, Georgios Kalampounias, Spyridon Alexis, et al.
Frontiers in Oncology|May 2, 2022
Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and ManagementThomas P Thomopoulos, Argiris Symeonidis, Alexandra Kourakli, et al.
Cureus|January 3, 2024
Lower-Risk Myelodysplastic Syndrome (MDS) Patients Exhibit Diminished Proteasome Proteolytic Activity and High Intracellular Reactive Oxygen Species (ROS) LevelsKalliopi Zafeiropoulou, Georgios Kalampounias, Spyridon Alexis, et al.
Frontiers in Oncology|November 15, 2024
Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification eraEvgenia Verigou, Theodora Chatzilygeroudi, Vasileios Lazaris, et al.
Annals of Hematology|October 26, 2019
Reversal of skin changes in smoldering myeloma with clinical presentation of POEMS syndrome with a lenalidomide-based regimenElena E Solomou, Panayiotis Marnellos, Agathoclis Agathokleous, et al.
Leukemia Research|June 19, 2004
Impaired clonogenic growth of myelodysplastic bone marrow progenitors in vitro is irrelevant to their apoptotic stateSotiria Michalopoulou, Ilina Micheva, Alexandra Kouraklis-Symeonidis, et al.
Current Issues in Molecular Biology|January 24, 2025
Prognostic Value of PSMB5 and Correlations with LC3II and Reactive Oxygen Species Levels in the Bone Marrow Mononuclear Cells of Bortezomib-Resistant Multiple Myeloma PatientsEva Plakoula, Georgios Kalampounias, Spyridon Alexis, et al.
Pageof 14